Search results
Results From The WOW.Com Content Network
Alcon Inc. Alcon Inc. ( German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people. [2]
ADK's pharmaceutical operations have expanded significantly over the past 17 years and it is today the largest wholesale distributor as well as retailer of pharmaceutical products in the country. Currently, ADK operates 5 pharmacies in Malé, 1 in Vilimalé and an optical showroom, with exclusive rights to advertise and sell Alcon ...
Novartis. / 47.5744252; 7.5764914. Pharmaceutical drugs, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health ( list...) Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical ...
The total cost to Novartis for the 77% stake in Alcon was $38.7 billion ($168 per share). In the deal's first phase, Novartis acquired a 25% stake in Alcon from Nestlé for $10.4 billion in July 2008.
Drug Houses of Australia is now a leading generic pharmaceutics and Chinese proprietary medicine (CPM) manufacturer based in Jurong, Singapore . It was sold to Strides Arcolab through a share purchase agreement with Haw Par Healthcare Limited, Singapore in September 2006 for approximately SGD$19.7 million.
Alcon Laboratories, already one of the largest employers and taxpayers in Tarrant County, is exploring a 250,000-square-foot expansion. ... irrigating solutions and contact lens products. By the ...
Pages in category "Pharmaceutical companies of Singapore" The following 3 pages are in this category, out of 3 total. This list may not reflect recent changes .
Aerie Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie's two lead product candidates are once-daily therapies for lowering intraocular pressure with mechanisms to treat patients ...